JP6377620B2 - グルコース取り込みを改善するための組成物および方法 - Google Patents

グルコース取り込みを改善するための組成物および方法 Download PDF

Info

Publication number
JP6377620B2
JP6377620B2 JP2015537790A JP2015537790A JP6377620B2 JP 6377620 B2 JP6377620 B2 JP 6377620B2 JP 2015537790 A JP2015537790 A JP 2015537790A JP 2015537790 A JP2015537790 A JP 2015537790A JP 6377620 B2 JP6377620 B2 JP 6377620B2
Authority
JP
Japan
Prior art keywords
group
liver
compound
compounds
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015537790A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015536324A (ja
JP2015536324A5 (enExample
Inventor
ブイ． デュランダー，ニキル
ブイ． デュランダー，ニキル
シー． ダス，バスカー
シー． ダス，バスカー
Original Assignee
ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ
ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ, ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ filed Critical ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ
Publication of JP2015536324A publication Critical patent/JP2015536324A/ja
Publication of JP2015536324A5 publication Critical patent/JP2015536324A5/ja
Application granted granted Critical
Publication of JP6377620B2 publication Critical patent/JP6377620B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2015537790A 2012-10-17 2013-10-16 グルコース取り込みを改善するための組成物および方法 Active JP6377620B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261714899P 2012-10-17 2012-10-17
US61/714,899 2012-10-17
PCT/US2013/065227 WO2014062794A1 (en) 2012-10-17 2013-10-16 Compositions and methods for improving glucose uptake

Publications (3)

Publication Number Publication Date
JP2015536324A JP2015536324A (ja) 2015-12-21
JP2015536324A5 JP2015536324A5 (enExample) 2016-12-01
JP6377620B2 true JP6377620B2 (ja) 2018-08-22

Family

ID=49486728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015537790A Active JP6377620B2 (ja) 2012-10-17 2013-10-16 グルコース取り込みを改善するための組成物および方法

Country Status (6)

Country Link
US (3) US9346835B2 (enExample)
EP (1) EP2909216B1 (enExample)
JP (1) JP6377620B2 (enExample)
CA (1) CA2887679C (enExample)
ES (1) ES2618374T3 (enExample)
WO (1) WO2014062794A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014062794A1 (en) * 2012-10-17 2014-04-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for improving glucose uptake
US10047107B2 (en) 2014-04-23 2018-08-14 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Small molecule analogs of E4orf1
AU2017324510B2 (en) 2016-09-07 2023-08-31 Temple University - Of The Commonwealth System Of Higher Education Compositions and methods for treatment of insulin resistance
WO2021026495A1 (en) 2019-08-07 2021-02-11 Texas Tech University System Ad36e40rf1: a therapeutic treatment for alzheimer's disease
TW202206062A (zh) 2020-04-24 2022-02-16 美國坦普大學 高等教育聯邦系統 治療非酒精性脂肪肝炎的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858592B2 (en) * 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
ES2472325T3 (es) 2005-11-30 2014-06-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Gen y proteína del adenovirus 36 E4 orf 1 y sus usos
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP2590665B1 (en) 2010-07-08 2015-09-16 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease
WO2012112670A1 (en) * 2011-02-16 2012-08-23 Albert Einstein College Of Medicine Of Yeshiva University Novel lipogenic inhibitors and uses thereof
WO2014062794A1 (en) * 2012-10-17 2014-04-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for improving glucose uptake

Also Published As

Publication number Publication date
US20170044189A1 (en) 2017-02-16
US20160113951A1 (en) 2016-04-28
ES2618374T3 (es) 2017-06-21
CA2887679A1 (en) 2014-04-24
EP2909216B1 (en) 2016-12-21
JP2015536324A (ja) 2015-12-21
EP2909216A1 (en) 2015-08-26
US20150266903A1 (en) 2015-09-24
US9346835B2 (en) 2016-05-24
US9714259B2 (en) 2017-07-25
CA2887679C (en) 2020-12-29
HK1214267A1 (en) 2016-07-22
WO2014062794A1 (en) 2014-04-24
US9469659B2 (en) 2016-10-18

Similar Documents

Publication Publication Date Title
JP2023030072A (ja) 併用療法
CA3139977A1 (en) Peptidomimetics for the treatment of coronavirus and picornavirus infections
CA2899321C (en) Fluorinated .alpha..nu.integrin antagonists
US20090054304A1 (en) Heterocyclic modulators of tgr5 for treatment of disease
CN106999462B (zh) 包含选择性s1p1受体激动剂的药物组合物
EA013973B1 (ru) Способы лечения кожной волчанки при помощи аминоизоиндолиновых соединений
EP2943181A1 (en) Pharmaceutical compositions
US9714259B2 (en) Compositions and methods for improving glucose uptake
EP3458448B1 (en) Fasn inhibitors for use in treating non-alcoholic steatohepatitis
CN107105660A (zh) 使用替唑尼特、其类似物或盐的前药的治疗组合物和治疗方法
JP2010535198A (ja) コハク酸のコリン塩を含む鼻腔内投与用医薬品組成物
KR101516677B1 (ko) 지방성 간 질환의 치료용 의약 조성물
US12414935B2 (en) Compounds and methods for the treatment of parasitic diseases
US10047107B2 (en) Small molecule analogs of E4orf1
CN115515601A (zh) 用己糖型单糖及其类似物治疗病毒感染的方法
WO2020081723A1 (en) Carbon monoxide prodrugs for the treatment of medical disorders
JP3142559B2 (ja) 止痒剤としての血小板活性化因子拮抗剤の用途
KR102267754B1 (ko) 정맥내 항바이러스 치료
HK1214267B (en) Compositions and methods for improving glucose uptake
HK1235406A1 (en) Small molecule analogs of e4orf1
HK1235406B (en) Small molecule analogs of e4orf1
US20160008317A1 (en) Therapeutic agent for ocular disease
WO2015089087A1 (en) Compositions and methods for treating respiratory injury or disease
TW202425969A (zh) 吲唑吡啶酮化合物及其用途
JP3654939B2 (ja) ドライバジャイナ治療剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161014

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161014

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170714

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170713

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180621

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180703

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180725

R150 Certificate of patent or registration of utility model

Ref document number: 6377620

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250